Boston Scientific Corp (BSX)

NYSE
Currency in USD
105.02
+0.05(+0.05%)
Closed
After Hours
105.00-0.02(-0.02%)

BSX Income Statement

Advanced Income Statement
Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa9,91311,88812,68214,24016,747
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-7.66%+19.92%+6.68%+12.29%+17.61%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa3,2423,7604,0034,3915,290
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa6,6718,1288,6799,84911,457
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-12.59%+21.84%+6.78%+13.48%+16.33%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa67.3%68.37%68.44%69.16%68.41%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa5,7196,3046,6467,4328,455
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-1.41%+10.23%+5.43%+11.83%+13.76%
aa.aaaa.aaaa.aaaa.aaaa.aa1,1431,2041,3231,4141,615
aa.aaaa.aaaa.aaaa.aaaa.aa3,7874,3594,5205,1905,984
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa9521,8242,0332,4173,002
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-48.01%+91.6%+11.46%+18.89%+24.2%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa9.6%15.34%16.03%16.97%17.93%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-358-337-460-243-305
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+19.19%+5.87%-36.5%+47.17%-25.51%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-361-341-470-265-305
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa341022-
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-26-34-45-57-18
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa5681,4531,5282,1172,679
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa-78-22--
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-779-664-340-5-381
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa-801,0771,1411,9842,282
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-111.64%+1,446.25%+5.94%+73.88%+15.02%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa-0.81%9.06%9%13.93%13.63%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa236443393436
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa-821,0416981,5911,846
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa---18
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa-821,0416981,5921,854
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-101.74%+1,369.51%-32.95%+128.08%+16.46%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa-0.83%8.76%5.5%11.18%11.07%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa33565622-
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa-1159856421,5701,854
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa-0.080.690.451.081.26
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-102.4%+953.15%-35.2%+140.76%+16.6%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa-0.080.690.451.071.25
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-102.44%+950.03%-34.96%+138.42%+16.82%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa1,416.71,422.31,430.51,4531,471.5
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa1,416.71,433.81,439.71,463.51,485.9
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-----
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa2,0752,9173,1693,6134,230
EBITDA Growth
aa.aaaa.aaaa.aa